Apparent response of subacute sclerosing panencephalitis to intrathecal interferon alpha
- 1 January 1991
- journal article
- case report
- Published by Wiley in Annals of Neurology
- Vol. 29 (1) , 97-99
- https://doi.org/10.1002/ana.410290118
Abstract
An 8‐years‐old boy with subacute sclerosing panencephalitis (SSPE) was treated with 1.0 to 3.0 × 106 IU human interferon alpha (IFN) by the intrathecal route weekly or fortnightly. Pronounced improvement of clinical and electroencephalographic findings were observed in a dose‐dependent manner. Our patient raises hope that IFN can induce sustained remission in patients with SSPE.Keywords
This publication has 12 references indexed in Scilit:
- Intrathecal synthesis of different alpha-interferons in patients with various neurological diseasesActa Neurologica Scandinavica, 2009
- Administration of human leukocyte interferon to patients with subacute sclerosing panencephalitisBrain & Development, 1989
- Clinical effects of MND-19 (Inosiplex) on subacute sclerosing panencephalitisBrain & Development, 1987
- Subacute sclerosing panencephalitis: remission after treatment withintraventricular interferonNeurology, 1986
- Intrathecal interferon in subacute sclerosing panencephalitisAnnals of Neurology, 1986
- INOSIPLEX THERAPY IN SUBACUTE SCLEROSING PANENCEPHALITISThe Lancet, 1982
- Long‐term follow‐up of patients with subacute sclerosing panencephalitis treated with inosiplexAnnals of Neurology, 1982
- The Variable Natural History of Subacute Sclerosing PanencephalitisArchives of Neurology, 1979
- The clinical spectrum and early diagnosis of Dawson's encephalitis: With preliminary notes on treatmentThe Journal of Pediatrics, 1969
- Subacute Sclerosing PanencephalitisNew England Journal of Medicine, 1968